BiomX Inc.
Market cap: $10,023,581
Exchange: ASE
Sector: Health Technology
BiomX Ltd engages in developing bacteriophage-based therapies for the treatment and prevention of diseases stemming from dysbiosis of the microbiome. The company was founded in March 2015 and is headquartered in Ness Ziona, Israel.